OBJECTIVE To synthesize updated evidence on the cost-effectiveness (CE) of interventions
to manage diabetes, its complications, and comorbidities. RESEARCH DESIGN AND …

OBJECTIVE To synthesize the cost-effectiveness (CE) of interventions to prevent and control
diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS We …

OBJECTIVE To estimate the cost-effectiveness of the multidisciplinary Risk Assessment and
Management Programme–Diabetes Mellitus (RAMP-DM) in primary care patients with type 2 …

Objective: Sitagliptin is a novel oral incretin enhancer that acts by inhibiting the dipeptidyl
peptidase 4 enzyme and is indicated in Europe as a treatment adjunct to metformin (MF) …

Diabetes mellitus is a chronic metabolic disease with deadly, disabling, and costly
consequences for individuals, families, communities, and countries. Although they are …

Mainstream health economic theory implies that an expected gain in health-related quality of
life (HRQoL) produces the same value for consumers, regardless of baseline health. Several …

Diabet. Med. 29, 5–13 (2012) Abstract An ideal biomarker should refine identification of
those at risk of disease occurrence or progression, improve prediction of complications of …

We evaluated the prevalence, awareness, treatment and control of hypertension in Korean
adults with diagnosed diabetes using nationally representative data. Among subjects aged⩾ …

Background: Statins have proven efficacy in the reduction of cardiovascular events, but the
financial impact of its widespread use can be substantial. Objective: To conduct a cost …

BACKGROUND Cardiovascular diseases are the leading cause of morbidity and mortality
worldwide. The aim of the study was to guide researchers and commissioners of …